D., Ph. D. Present Position

2010 “In vivo blocking of CA125/mesothelin-dependent cell adhesion prevents ovarian cancer peritoneal metastasis”. Denarda Dangaj, Amber Roberts, Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation.Society of Gynecologic Oncologists (SGO) 41^st Annual Meeting on Women's Cancer. March 14-17, San Francisco, CA.

2010 “MTB Hsp70-scFv Fusion and Self Assembling Proteins Targeting Mesothelin Control Tumor Growth and Augment Tumor Specific T Cell Responses In A Murine Model of Ovarian Cancer” Jianping Yuan, Pierre Leblanc, Elda Righi, Svetlana Korochkina, Jacalyn Rosenblatt, Brett Gotzbecker, Dimitris Tzachanis, Michael Santosuosso, Sandra Orsulic, Heidi Mills, Nathalie Scholler, David Avigan, Jeff Gelfand and Mark C. Poznansky. Poster presentation. Symposium Dana Farber/ Harvard Cancer Center ovca/ breast ca meeting. March 5, 2010, Boston, MA.

2010 “Ovarian tumor infiltrating lymphocytes B (TIL-B) are capable of synthesis and secretion of both pro- and anti-angiogenic factors.” Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, George Coukos, Phyllis Gimotty and Nathalie Scholler - Poster presentation, 13^th Annual Meeting of the Translational Research Cancer Centers Consortium conference (TRC3), The Ohio State University - March 1-2- Colombus, OH- First Price poster winner.

2010 “The binding of mannose receptor by tumor-released GPI-anchor proteins controls tumor-associated macrophage phenotype” Authors: Denarda Dangaj, Selene Nunez-Cruz, Aizhi Zhao, Raphael Sandaltzopoulos and Nathalie Scholler. Poster presentation. 13^th Annual Meeting of the Translational Research Cancer Centers Consortium conference, The Ohio State University - March 1-2- Colombus, OH.

2009 “Development of a screening strategy to identify affinity reagents against formalin-fixed antigen”. Natalia Diaz-Rodriguez, Aizhi Zhao, Nathalie Scholler. Poster presentation. Short-term Elective Research (STER) Summer Student Symposium – September 11 – University of Pennsylvania, Philadelphia, PA.

2009 “Dual Specificity Suicide Gene Therapy Using Targeted Nanoparticles Directed against Ovarian Cancer”. Andrew M. Prantner, Patricia Ohana, Abraham Hochberg, Jerry D. Glickson, George Coukos and Nathalie Scholler. Poster presentation. Biomedical Post Doctoral Research Symposium 2009. University of Pennsylvania, Philadelphia, PA.

2009 “Tumor infiltrating-B cells (TIL-B) exhibit a regulatory phenotype in a transgenic mouse model of serous ovarian cancer”. Selene Nunez-Cruz, Matthew Guerra, Denise Connolly, George Coukos, Phyllis Gimotty and Nathalie Scholler. Poster presentation. Biomedical Post Doctoral Research Symposium 2009. University of Pennsylvania, Philadelphia, PA.

2009 “Development and validation of a ScFv specific for human glypican-3”. Yonghai Li, Aizhi Zhao, Hong Li, Oluwasayo Adeyemo, Nathalie Scholler, David Kaplan. Poster presentation. Department of Medicine Research Day - June 5 - University of Pennsylvania, Philadelphia, PA.

2009 “Construction of a large scFv yeast display library and isolation of TEM1-specific antibodies of high affinity for targeted-imaging and therapy of cancer” Zhao ., Li C., Nunez-Cruz S., Prantner A.M., Coukos G., Siegel D.L. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - Philadelphia, PA.

2009 “Rescue of anti-tumor macrophages using mannose-receptor targeted recombinant antibodies for ovarian cancer therapeutics” Dangaj D., Sandaltzopoulos R., Zhao A., Coukos G. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Developing a universal method to prepare scFv-modified nanoparticles for ovarian cancer diagnosis and therapy”. Prantner A.M., Glickson J.D., Coukos G. and Scholler N. Key note presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Development of an orthotopic mouse model of serous ovarian cancer for in vivo imaging” Nunez-Cruz S., Prantner A.M., Zhao A., Roberts A., Secreto A., Connolly D., Danet-Denoyers G., Coukos G. and Scholler N. Poster presentation. CRRWH annual retreat, University of Pennsylvania - May 27- Philadelphia, PA.

2009 “Genetic Approach to Study Complement Role in Ovarian Cancer”. Nunez-Cruz S., Connolly D., Roberts A., Lambris J.D., Coukos G. and Scholler N. The Journal of Immunology, 2009, 182, 88.24; AAI 2009 - Poster or oral presentations. -May 8-12 - Seattle, WA. Travel Award, Selene Nunez-Cruz.

2009 “Identification of high affinity scFv antibodies against mouse and human tumor endothelial marker 1 (TEM1) using yeast-display scFv library derived from autoimmune patients”. Zhao, A, Li, C., Coukos C, Siegel D and Scholler N. The Journal of Immunology, 2010, 184, 101.20; AAI 2009- Poster or oral presentations. May 8-12 - Seattle, WA. Travel Award, Aizhi Zhao.

2009 “Genetic Approach to Study Complement Role in Ovarian Cancer”. Nunez-Cruz S., Connolly D., Roberts A., Lambris J.D., Coukos G. and Scholler N. Poster presentation. 12^th Annual Meeting of the Translational Research Cancer Centers Consortium conference, University of Pennsylvania- March 6-7- Philadelphia, PA Third Price poster winner.

2009 “Blocking the chemical crosstalk between tumor cells and macrophages with recombinant antibodies to trigger tumor immune rejection.” Dangaj D, Sandaltzopoulos R, Coukos G and Scholler N. Poster presentation. 12^th Annual Meeting of Translational Research Cancer Centers Consortium conference, University of Pennsylvania- March 6-7- Philadelphia, PA

2009 “Development of a universal method for targeting nanoparticles with functionally intact scFv”. Prantner A.M., Glickson J.D., Coukos G and Scholler N. 12^th Annual Meeting of the Translational Research Cancer Center s Consortium conference, Poster presentation University of Pennsylvania- March 6-7- Philadelphia, PA

2008 “In vivo Modeling and Detection of the Ovarian Cancer Vascular Marker TEM1”. Li C., Swails JC, Hasegawa K, O'Brien-Jenkins A, Liu Y, El-Deiry WS, Scholler N, Divgi C, Gimotty PA, Grasso L, Coukos G –Third International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Poster and oral presentations. AACR - September 22, 2008- Philadelphia, PA. Award winner.

2008 “Novel Tumor Vascular Markers: Useful Biomarkers and Therapeutic Targets in Epithelial Ovarian Cancer”. Sasaroli D., Kougioumtzidou E., Hammond R., Buckanovich R.J., Sandaltzopoulos R., Scholler N., Gimotty P.A. and Coukos G. Poster presentation Second International Conference on Ovarian Cancer: State of the Art and Future Directions - June 26-July 1, 2008 - Rhodes, Greece

2008 “The Influence of Ovarian Cancer Risk-Status on the Diagnostic Performance of the Biomarkers Mesothelin, HE4 and CA125.” Shah C., Lowe K., Paley P., Wallace E., Anderson G., McIntosh M., Andersen R., Scholler N., Bergan L., Thorpe J., Urban N., Drescher C. Poster presentation Joint Meeting of the Western Association of Gynecologic Oncologists (WAGO) and the Felix Rutledge Society (FRS) - June 11-14, 2008 - Fairmont Sonoma Mission Inn, Sonoma, CA.

2008 “HE4 Bead-Based ELISA: Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies).” Forrest R., Scholler N., Lowe K., Bergan L., Kampani A., Thorpe J., Gross J., Garvik B. and Urban N. - Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA.

2008 “Use of cancer-specific in vivo-biotinylated recombinant antibodies (Biobodies) for serum biomarker discovery.” Scholler N., Gross J.A., Garvik B., Wells L., Liu Y., Loch C.M., Ramirez A.B., McIntosh M.W., Lampe P.D. and Urban N. Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA.

2008 “Vascular Proteins Predict Clinical Outcome in Ovarian Cancer.” Sasaroli D., Gimotty P.A., Hammond R., Seedial T., Buckanovich R.J., Katsaros D., Scholler N. and Coukos G. Poster presentation. Canary Foundation Early Detection Symposium, May 21-22, Stanford, CA

2005 “Use of a yeast library of human antibody recognition sequences to develop diagnostic reagents.” Scholler N, Garvik B and Urban N. Poster presentation. XXII International Conference on Yeast Genetics and Molecular Biology, Bratislava, Slovakia.